Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Toxicology Congress 2017

Sessions/Tracks

We welcome you to the 8th World Congress on Toxicology and Pharmacology which is going to be held during April 13-15, 2017 at Dubai, UAE with the theme “Communing Toxicology & Pharmacology Investigations for Human Health”. Toxicology Congress 2017 will bring together Leading Principle Investigators, Pharmacologists, Toxicologists, Clinicians, CRO’s, Biotech and Pharmaceutical industry professionals to discuss the advancements in health care therapeutics and clinical trials.

Track 1: Toxicology

Toxicology is the scientific study of harmful effects of chemical, biological and physical agents in biological systems that establish the extent of damage in living organisms. It includes observing symptoms, mechanisms, detection and treatments of toxic substances, in certain relation to the poisoning of humans. It consists of environmental agents and chemical compounds, as well as Pharmaceutical Compounds that are manufactured for medical use by humans. These substances may produce toxic effects in living organisms including disturbance in growth patterns, discomfort, disease and death. Toxicology is the qualitative and quantitative study of the adverse effects of chemicals and other materials on living organisms. The dose of the substance is an important factor in toxicology, as it has a relationship with the effects on the individual. Factors that influence toxicity include the dose, the route of exposure, shape and structure of the chemical, the species, individual human factors and environment. Toxicology and Pharmacology are both studies that involve in assessing the properties of chemicals and their actions on the body, but differ significantly in other areas. Pharmacology focuses on the therapeutic effects of pharmaceutical substances and how they can be used most effectively for medical purpose. Whereas, toxicology is closely related to the adverse effects that can occur in living organisms that come into contact with chemical compounds. Toxicologists are also concerned with determining the risk of certain substances with risk assessment tools.

Related Conferences: Toxicology Conferences | Pharmacology Conferences | Pharmaceutical Conferences

9th Global Toxicology and Pharmacology Meeting, July 17-19, 2017, Lisbon, Portugal; 10th Global Summit on Toxicology and Applied Pharmacology, July 24-26, 2017, Toronto, Canada; 12th Applied Pharmacology Summit, October  2-4, 2017, London, UK; 13th International Conference on Genetic Toxicology and Cancer Biology, November 2-3, 2017, San Antonio, USA; 15th International Conference on Toxicology and Clinical Pharmacology, December 14-16, 2017, Dubai, UAE; 16th International Conference on Occupational Toxicology and Industrial Health, December 14-15, 2017, Dubai, UAE; 14th International Conference on Forensic Science and Clinical Toxicology, November 2-3, 2017, San Antonio, USA; 11th International Conference on Environmental Toxicology and Ecological Risk Assessment, September 21-22, 2017, Toronto, Canada; 3rd International Conference on Genomics and Toxicogenomics, September 21-22, 2017, Toronto, Canada; The XIV International Congress of Toxicology (ICTXIV), October 02-06, 2016, Mexico; Argentine Toxicological Association 34th Interdisciplinary Toxicology Conference, September 21–23, 2016, Cordoba, Argentina; 19th International Congress on In Vitro Toxicology– French Society of Toxicology, October 17–20, 2016, Juan-les-Pins, France; 53rd European Congress of the European Societies of Toxicology, September 10–13, 2017, Bratislava, Slovakia; 7th International Conference on Environmental Mutagens in Human Populations (ICEMHP), November 2016, Thailand; Society of Environmental Toxicology and Chemistry (SETAC); IUTOX: International Union of Toxicology; EUROTOX; SOT: Society of Toxicology; ABD: American Board of Toxicology

Track 2: Toxicology and Risk Assessment

Chemical risk assessment methodologies facilitate both scientific and data-informed decision making and also is progressively expected to provide more precise predictions of actual risk. Risk assessment includes the characterization of the uncertainties inherent in the process of inferring risk. Toxicology data helps to determine the risk of exposure to certain chemicals. The practices of risk assessment are used to assess the related health risks to provide a scientific basis for regulatory standards development and risk management decision making for human health protection. The presence of chemicals in our environment is a subject of deep interest owing to the many potential adverse health effects to humans following exposure to these chemicals. The validity of an estimation of risk derived from a risk assessment depends greatly on the quality and accuracy of data. Where data do not exist or are contradictory, regulatory agencies are required to rely on default values, uncertainty factors, and modeling approaches to fill in the blanks. These defaults and extrapolations introduce uncertainty into the risk estimates. New methodologies and testing methods could fill key data gaps, clarify data inconsistencies, or otherwise reduce uncertainty. If applied appropriately, these approaches have the potential to improve the accuracy and scientific credibility of regulatory decision making. Human health risk assessment is the process of investigating information to determine whether an environmental hazard might cause harm to exposed persons. The risk-assessment process incorporates many disciplines of Toxicology.

Related Conferences: Risk Assessment Conferences | Toxicology Conferences | Environmental Toxicology Conferences

11th International Conference on Ecological Risk Assessment , September 21-22, 2017, Toronto, Canada; 14th International Conference on Clinical Toxicology, November 2-3, 2017, San Antonio, USA; 16th International Conference on Occupational Toxicology and Industrial Health, December 14-15, 2017, Dubai, UAE; 9th Global Pharmacology and  Toxicology Meeting, July 17-19, 2017, Lisbon, Portugal; 10th Global Summit on Toxicology and Applied Pharmacology, July 24-26, 2017, Toronto, Canada; 13th International Conference on Cancer Biology  and Genetic Toxicology, November 2-3, 2017, San Antonio, USA; 12th Euro-Global Summit on Applied Pharmacology and Toxicology, October  2-4, 2017, London, UK; 15th International Conference on Toxicology and Clinical Pharmacology, December 14-16, 2017, Dubai, UAE; 3rd International Conference on Genomics and Toxicogenomics, September 21-22, 2017, Toronto, Canada; Argentine Toxicological Association 34th Interdisciplinary Toxicology Conference, September 21–23, 2016; 7th International Conference on Environmental Mutagens in Human Populations (ICEMHP), November 2016, Thailand; Society of Toxicology’s 56th Annual Meeting, March 12–16, 2017, Baltimore, Maryland, USA; The XIV International Congress of Toxicology (ICTXIV), October 02-06, 2016, Mexico, ICT 2016; 11th International Particle Toxicology Conference September 26- 30 2016, Singapore; Society of Toxicology of Canada; Swedish Society of Toxicology; Estonian Society of Toxicology; British Toxicology Society; Argentine Toxicological Association

Track 3: Analytical Toxicology

Analytical toxicology is the detection, identification, and measurement of foreign compounds in biological and other specimens. Analytical methods are available for a wide range of compounds like chemicals, pesticides, drugs and natural toxins. Analytical toxicology is used in the diagnosis, management, prognosis, and prevention of poisoning. Analytical toxicology laboratories may be involved in activities such as the assessment of exposure following chemical incidents, therapeutic drug monitoring, monitoring the drugs of abuse and forensic analyses. They may also be involved in research like determining the pharmacokinetic and toxicokinetic properties. Liquid chromatography-mass spectrometry and Gas chromatography-mass spectrometry are generally used today in analytical toxicology. While planning the development of an analytical toxicology service there are a number of considerations. These comprise the pattern of poisoning and, therefore, the specific substances for which analyses will be required, the existing infrastructure, the availability of ongoing technical support, spare parts and reagents from suppliers, the availability of a team of trained staff and the capacity to train new staff and provide continuing professional development.

Related Conferences: Analytical Toxicology Conferences | Clinical Toxicology Conferences | Forensic Conferences 

15th International  Summit on Toxicology and Clinical Pharmacology, December 14-16, 2017, Dubai, UAE; 14th International  Clinical Toxicology Meeting , November 2-3, 2017, San Antonio, USA; 11th International Conference on Environmental Toxicology and Ecological Risk Assessment, September 21-22, 2017, Toronto, Canada; 16th International Conference on Occupational Toxicology and Industrial Health, December 14-15, 2017, Dubai, UAE; 9th Global Pharmacology and  Toxicology Meeting, July 17-19, 2017, Lisbon, Portugal; 10th Global Summit on Applied Pharmacology  and Toxicology, July 24-26, 2017, Toronto, Canada; 13th International Conference on Cancer Biology  and Genetic Toxicology, November 2-3, 2017, San Antonio, USA; 12th Euro-Global Summit on Applied Pharmacology and Toxicology, October  2-4, 2017, London, UK; 3rd International Conference on Toxicogenomics  and Genomics, September 21-22, 2017, Toronto, Canada; 9th Annual Australasian College of Toxicology & Risk Assessment, September 22–23, 2016, Adelaide, Australia; Australasian Society of Clinical and Experimental Pharmacologists & Toxicologists-MPGPCR 2016 Joint Scientific Meeting, November 27–30, 2016, Melbourne, Australia; 19th International Congress on In Vitro Toxicology– French Society of Toxicology, ESTIV & SPTC Joint Congress, October 17–20, 2016, Juan-les-Pins, France; ANZFSS 23rd International Symposium on the Forensic Sciences, 18-23 September, 2016, New Zealand; 53rd European Congress of the European Societies of Toxicology, September 10–13, 2017, Bratislava, Slovakia; IUTOX: International Union of Toxicology; EUROTOX; SOT: Society of Toxicology; German Society of Toxicology; Academy of Toxicological Sciences

Track 4: Genotoxicity

Genotoxicity describes the property of chemical compounds that damages the genetic information within a cell causing mutations, which may lead to cancer. Genotoxic chemicals exert their adverse effect through interaction with genetic material (DNA) of cells. Genotoxicity testing of new chemical entities is an integral part of the drug development process and is a regulatory necessity prior to the approval of new drugs. To assay for genotoxic molecules, researchers assay for DNA damage in cells exposed to the toxic substrates. Techniques like in vitro and in vivo Toxicology Tests, Ames Assay and Comet Assay have been developed to determine the chemicals' potential to cause DNA damage that may lead to cancer. Genotoxicity tests are designed to detect drugs which can cause genetic damage directly or indirectly by various mechanisms of action. Compounds which are identified as genotoxic in these tests have the ability to be human carcinogens and ultimately may induce cancer and heritable defects. Genotoxicity testing of new chemical entities is an integral part and is a regulatory requirement prior to the approval of new drugs, in Drug Development process. Late stage failures can reduced by identifying genotoxicity at an early stage in Drug Discovery rather than during regulatory assessment.

Related Conferences: Genetic Toxicology ConferencesMedical Toxicology Conferences | Toxicology Conferences

3rd International Conference on Toxicogenomics  and Genomics, September 21-22, 2017, Toronto, Canada; 9th Global  Symposium on Pharmacology and Toxicology, July 17-19, 2017, Lisbon, Portugal; 10th Global Summit on Toxicology and Applied Pharmacology, July 24-26, 2017, Toronto, Canada; 11th International Conference on Environmental Toxicology and Ecological Risk Assessment, September 21-22, 2017, Toronto, Canada; 12th Applied Pharmacology Summit, October  2-4, 2017, London, UK; 13th International Conference on Genetic Toxicology and Cancer Biology, November 2-3, 2017, San Antonio, USA; 14th International Conference on Forensic Science and Clinical Toxicology, November 2-3, 2017, San Antonio, USA;  15th International Congress on Toxicology and Clinical Pharmacology, December 14-16, 2017, Dubai, UAE; 16th International Meetings on Occupational Toxicology and Industrial Health, December 14-15, 2017, Dubai, UAE; The XIV International Congress of Toxicology (ICTXIV), October 02-06, 2016, Mexico; 19th International Congress on In Vitro Toxicology– French Society of Toxicology, ESTIV & SPTC Joint Congress, October 17–20, 2016, Juan-les-Pins, France;  Argentine Toxicological Association 34th Interdisciplinary Toxicology Conference, September 21–23, 2016, Cordoba, Argentina; 53rd European Congress of the European Societies of Toxicology, September 10–13, 2017, Bratislava, Slovakia; 7th International Conference on Environmental Mutagens in Human Populations (ICEMHP), November 2016, Thailand; Egyptian Society of Toxicology; French Society of Clinical Toxicology; Japanese Society of Toxicology; Latvian Society of Toxicology; Polish Society of Toxicology

Track 5: Forensic Toxicology

Forensic toxicology uses toxicology and other disciplines such as analytical chemistry, clinical chemistry and pharmacology to aid medical or legal investigation of drug use, poisoning and death. It deals with the investigation of toxic substances, poisonous products and environmental chemicals. The primary concern of Forensic Toxicology is to obtain and interpret the results. Toxicological analysis can be done to various kinds of samples. Forensic toxicology involves not only determining the presence of Toxic substance in the post-mortem body, but how the body’s natural processes affect the substance, including chemical change and dilution. Forensic toxicologists perform scientific tests on tissue samples and bodily fluids to identify any chemicals or drugs present in the body. The choice of method for testing is highly depends on the material on which the testing is performed and what kind of substance one expects to find. Analytical methods used in forensic toxicology should be carefully tested by performing a validation of the method to ensure definite results at all times. Forensic toxicologists also work on cases involving environmental contamination, to determine the impact of chemical spills on living organisms. Investigators rely on the forensic toxicologist to make reliable conclusions about the impact a specific amount of a specific substance would have on a specific individual. Currently, forensic toxicology is the study of drugs, alcohol and poisons, including their chemical composition, identification and preparations. It comprises knowledge about the absorption, distribution and elimination process of such substances in the body, as well as the manner in which the body responds to their presence and the factors which define Drug Safety and efficacy.

Related Conferences: Forensic Toxicology Conferences | Clinical Toxicology Conferences | Forensic Conferences

14th International Conference on Forensic Science and Clinical Toxicology, November 2-3, 2017, San Antonio, USA; 16th International Meetings on Occupational Toxicology and Industrial Health, December 14-15, 2017, Dubai, UAE;  15th Global Congress on Toxicology and Clinical Pharmacology, December 14-16, 2017, Dubai, UAE; 10th Global Summit on Toxicology and Applied Pharmacology, July 24-26, 2017, Toronto, Canada; 3rd International Conference on Toxicogenomics  and Genomics, September 21-22, 2017, Toronto, Canada; 12th Applied Pharmacology Summit, October  2-4, 2017, London, UK; 9th Global  Symposium on Pharmacology and Toxicology, July 17-19, 2017, Lisbon, Portugal; 11th International Conference on Environmental Toxicology and Ecological Risk Assessment, September 21-22, 2017, Toronto, Canada; 13th International Conference on Genetic Toxicology and Cancer Biology, November 2-3, 2017, San Antonio, USA; ANZFSS 23rd International Symposium on the Forensic Sciences, 18-23 September, 2016, New Zealand; 9th Annual Australasian College of Toxicology & Risk Assessment, September 22–23, 2016, Adelaide, Australia; Argentine Toxicological Association 34th Interdisciplinary Toxicology Conference, September 21–23, 2016; 7th International Conference on Environmental Mutagens in Human Populations (ICEMHP), November 2016, Thailand; The XIV International Congress of Toxicology (ICTXIV), October 02-06, 2016, Mexico, ICT 2016; Estonian Society of Toxicology; European Association of Poison Centres and Clinical Toxicologists; EUROTOX; Korean Society of Toxicology; Russian Society of Toxicology

Track 6: Food Safety and Environmental Toxicology

Food safety is a discipline which describes preparation, handling and storage of food in ways that avoid foodborne illness. This involves a number of routines that should be followed to avoid potentially severe health hazards. Food safety includes the origins of food including the practices relating to food labelling, food additives, pesticide residues and food hygiene as well as policies on Biotechnology and food. Food can transmit disease from person to person as well as help as a growth medium for bacteria that can cause food poisoning. In developed countries there are sophisticated standards for food preparation, whereas in lesser developed countries the main issue is simply the availability of sufficient safe water, which is usually a critical item. Environmental toxicology is a field of science concerned with the study of the harmful effects of various physical, chemical and biological agents on living organisms. Harmful effects of biological and chemical agents can include toxicants from pesticides, pollutants, fertilizers and insecticides all of which can impact an organism and its population through shifts in species diversity and abundance. Living organisms can be exposed to Toxicants at various stages of their life cycle. The amount of toxicity can vary depending on where the organism is found within its food web.

Related Conferences: Environmental Toxicology Conferences | Food Safety Conferences | Toxicology Conferences

11th International Conference on Environmental Toxicology and Ecological Risk Assessment, September 21-22, 2017, Toronto, Canada; 13th International Conference on Cancer Biology  and Genetic Toxicology, November 2-3, 2017, San Antonio, USA; 15th International  Summit on Toxicology and Clinical Pharmacology, December 14-16, 2017, Dubai, UAE; 14th International  Clinical Toxicology Meeting , November 2-3, 2017, San Antonio, USA; 16th International Conference on Occupational Toxicology and Industrial Health, December 14-15, 2017, Dubai, UAE; 9th Global Pharmacology and  Toxicology Meeting, July 17-19, 2017, Lisbon, Portugal; 10th Global Summit on Applied Pharmacology  and Toxicology, July 24-26, 2017, Toronto, Canada; 12th Euro-Global Summit on Applied Pharmacology and Toxicology, October  2-4, 2017, London, UK; 3rd International Conference on Toxicogenomics  and Genomics, September 21-22, 2017, Toronto, Canada; 7th International Conference on Environmental Mutagens in Human Populations (ICEMHP), November 2016, Thailand; 11th International Particle Toxicology Conference September 26- 30 2016, Singapore; Argentine Toxicological Association 34th Interdisciplinary Toxicology Conference, September 21–23, 2016; Society of Toxicology’s 56th Annual Meeting, March 12–16, 2017, Baltimore, Maryland, USA; The XIV International Congress of Toxicology (ICTXIV), October 02-06, 2016, Mexico, ICT 2016; German Society of Toxicology; Hellenic Society of Toxicology; International Neurotoxicology Association (INA); Iranian Society of Toxicology (IST); Irish Society of Toxicology

Track 7: Toxicology Applications

Application of procedures and principles of toxicology to prevent adverse health effects from drug candidates. To estimate the safety of potential drug candidates in the drug development process is the primary objective of toxicology studies. This can be done by using relevant animal models and validated procedures. The ultimate goal is to translate the animal model responses into an understanding of the risk for human subjects. To this end, the toxicologist must be conscious of the international guidelines for safety evaluation, as well as traditional and nontraditional toxicology models. Toxicology profile consists of safety Pharmacology, acute and subchronic toxicology, chronic toxicology, ADME studies, genetic toxicology, reproductive and developmental toxicology and an evaluation of carcinogenic potential. The development of novel drugs requires non-clinical safety studies to be performed on candidate drug compounds. Such studies typically assess general toxicology safety pharmacology and Genetic Toxicity test batteries. These studies notify development of candidate drugs from the “discovery phase” through clinical development to regulatory submission and registration. Less importance was placed on the evaluation of safety issues for projects while still in the drug design phase. Therefore, this led to a number of major failures of candidate drugs in early development due to toxicological issues. In response to this costly attrition, many pharmaceutical companies have now dedicated in “Discovery-phase Toxicology” or “Discovery Safety” to detect likely hazards and to take steps to design out or significantly reduce unwanted properties at an earlier stage, with the ultimate aim of improving the probability of success in non-clinical and clinical drug development.

Related Conferences: Toxicology Conferences | Clinical Toxicology Conferences | Medical Toxicology Conferences

11th International Symposium on Environmental Toxicology and Ecological Risk Assessment, September 21-22, 2017, Toronto, Canada; 3rd International Symposium on Toxicogenomics  and Genomics, September 21-22, 2017, Toronto, Canada; 12th Euro-Global Summit on Applied Pharmacology and Toxicology, October  2-4, 2017, London, UK;  13th International Summit on Cancer Biology  and Genetic Toxicology, November 2-3, 2017, San Antonio, USA; 15th International  Meeting on Toxicology and Clinical Pharmacology, December 14-16, 2017, Dubai, UAE; 14th International  Clinical Toxicology Meeting , November 2-3, 2017, San Antonio, USA; 16th International Congress on Occupational Toxicology and Industrial Health, December 14-15, 2017, Dubai, UAE; 9th Global Pharmacology and  Toxicology Meeting, July 17-19, 2017, Lisbon, Portugal; 10th Global Conference on Applied Pharmacology  and Toxicology, July 24-26, 2017, Toronto, Canada; American College of Toxicology- 37th Annual Meeting on Toxicology, November 6–9, 2016, Baltimore Marriott Waterfront, Baltimore, Maryland; 19th International Congress on In Vitro Toxicology– French Society of Toxicology, ESTIV & SPTC Joint Congress, October 17–20, 2016, Juan-les-Pins, France; 9th Annual Australasian College of Toxicology & Risk Assessment, September 22–23, 2016, Adelaide, Australia; 7th International Conference on Environmental Mutagens in Human Populations (ICEMHP), November 2016, Thailand; The XIV International Congress of Toxicology (ICTXIV), October 02-06, 2016, Mexico, ICT 2016; German Society of Toxicology; Academy of Toxicological Sciences; ABD: American Board of Toxicology; STC: Society of Toxicology of Canada; American College of Medical Toxicology

Track 8: Pharmacology

Pharmacology is the scientific study of drug action on biological systems. It is the study of the interactions between a living organism and drugs. If substances have medicinal properties, they are considered pharmaceuticals. Pharmacological studies range from the effects of chemical agents upon subcellular mechanisms, to those that deal with the potential hazards of pesticides and herbicides, to those that focus on the treatment of major diseases by drug therapy. It involves examining the interactions between chemical substances and living systems, with a view to determining the properties of drugs and drug actions, including the drug molecules and drug receptors interactions and how these interactions elicit an effect. The study of chemicals requires good knowledge of the biological system affected. With the knowledge of biochemistry and cell biology increasing, the field of pharmacology has also changed significantly. It is now possible to design chemicals that act on specific cellular signaling or metabolic pathways by affecting sites directly on cell-surface receptors, through molecular analysis of receptors.

Related Conferences: Pharmacology Conferences | Toxicology Conferences | Pharmaceutical Conferences

10th Global Conference on Applied Pharmacology  and Toxicology, July 24-26, 2017, Toronto, Canada; 15th International  Meeting on Clinical Pharmacology  and Toxicology, December 14-16, 2017, Dubai, UAE; 9th Global Toxicology and Pharmacology Meeting, July 17-19, 2017, Lisbon, Portugal; 12th Euro-Global Summit on Applied Pharmacology and Toxicology, October  2-4, 2017, London, UK; 11th International Symposium on Environmental Toxicology and Ecological Risk Assessment, September 21-22, 2017, Toronto, Canada; 3rd International Symposium on Toxicogenomics  and Genomics, September 21-22, 2017, Toronto, Canada; 13th International Summit on Cancer Biology  and Genetic Toxicology, November 2-3, 2017, San Antonio, USA; 14th International  Clinical Toxicology Meeting , November 2-3, 2017, San Antonio, USA; 16th International Congress on Occupational Toxicology and Industrial Health, December 14-15, 2017, Dubai, UAE; Australasian Society of Clinical and Experimental Pharmacologists & Toxicologists-MPGPCR 2016 Joint Scientific Meeting, November 27–30, 2016, Melbourne, Australia; American College of Toxicology- 37th Annual Meeting on Toxicology, November 6–9, 2016, Baltimore Marriott Waterfront, Baltimore, Maryland; ANZFSS 23rd International Symposium on the Forensic Sciences, 18-23 September, 2016, New Zealand; The XIV International Congress of Toxicology (ICTXIV), October 02-06, 2016, Mexico, ICT 2016; Society of Toxicology 56th Annual Meeting, March 12–16, 2017, Baltimore, Maryland, USA; Society of Environmental Toxicology and Chemistry (SETAC); IUTOX: International Union of Toxicology; EUROTOX; SOT: Society of Toxicology; German Society of Toxicology

Track 9: Applied Pharmacology

Pharmacology deals with the basis, therapeutics uses of drugs, physiological action and properties of action. Applied pharmacology helps to measure the data obtained from the clinical studies and can correlate it with the clinical processes. Applied pharmacology is the study of how drugs affect body. Drugs can be used to both maintain a healthy lifestyle and treat or cure disease. It also provides explanation for different drugs having connected with the pharmacological action. It gives clarifications about drug interactions and the action of various drugs on the many organs in the body when they are in diseased state with side effects contradictions. Applied pharmacology makes it possible not only to explain to the doctor the action of drugs in the human body, but also in evaluating the efficacy of drugs in a particular disease condition.

Related Conferences: Pharmacology Conferences | Pharmaceutical Meetings | Clinical Pharmacology Conferences

15th International  Meeting on Clinical Pharmacology  and Toxicology, December 14-16, 2017, Dubai, UAE; 9th Global Toxicology and Pharmacology Meeting, July 17-19, 2017, Lisbon, Portugal; 12th Euro-Global Summit on Applied Pharmacology and Toxicology, October  2-4, 2017, London, UK; 10th Global Conference on Applied Pharmacology  and Toxicology, July 24-26, 2017, Toronto, Canada; 11th International Symposium on Environmental Toxicology and Ecological Risk Assessment, September 21-22, 2017, Toronto, Canada; 3rd International Symposium on Toxicogenomics  and Genomics, September 21-22, 2017, Toronto, Canada; 13th International Summit on Cancer Biology  and Genetic Toxicology, November 2-3, 2017, San Antonio, USA; 14th International  Clinical Toxicology Meeting , November 2-3, 2017, San Antonio, USA; 16th International Congress on Occupational Toxicology and Industrial Health, December 14-15, 2017, Dubai, UAE; ANZFSS 23rd International Symposium on the Forensic Sciences, 18-23 September, 2016, New Zealand; Australasian Society of Clinical and Experimental Pharmacologists & Toxicologists-MPGPCR 2016 Joint Scientific Meeting, November 27–30, 2016, Melbourne, Australia; American College of Toxicology- 37th Annual Meeting on Toxicology, November 6–9, 2016, Baltimore Marriott Waterfront, Baltimore, Maryland; Society of Toxicology 56th Annual Meeting, March 12–16, 2017, Baltimore, Maryland, USA; The XIV International Congress of Toxicology (ICTXIV), October 02-06, 2016, Mexico, ICT 2016; The Toxicology Society of South Africa; The Toxicology Society of Taiwan; The Turkish Society of Toxicology; Toxicology Cuban Society (SOCTOX); Ukrainian Toxicology Society

Track 10: Environmental Pharmacology   

Environmental pharmacology is a moderately new and rising forte of pharmacology. It includes the investigation of quality environment connection, drug-environment connection and poison environment cooperation. It is essential to accentuate at this phase the distinctive terms utilized tradable with natural Pharmacology incorporate ecophar‐ macology, and pharmacoenvironmentology, Ecotoxicology. Nonetheless, a nearby likeness exists between ecological pharmacology and ecotoxicology. Environmental pharmacology involves the investigation of ecological science, drug, nature, hereditary qualities and science.

Related Conferences: Environmental pharmacology ConferencesEcological ConferencesPharma Conferences

11th International Conference on Environmental Toxicology and Ecological Risk Assessment, September 21-22, 2017, Toronto, Canada; 13th International Conference on Cancer Biology  and Genetic Toxicology, November 2-3, 2017, San Antonio, USA; 15th International  Summit on Toxicology and Clinical Pharmacology, December 14-16, 2017, Dubai, UAE; 14th International  Clinical Toxicology Meeting , November 2-3, 2017, San Antonio, USA; 16th International Conference on Occupational Toxicology and Industrial Health, December 14-15, 2017, Dubai, UAE; 9th Global Pharmacology and  Toxicology Meeting, July 17-19, 2017, Lisbon, Portugal; 10th Global Summit on Applied Pharmacology  and Toxicology, July 24-26, 2017, Toronto, Canada; 12th Euro-Global Summit on Applied Pharmacology and Toxicology, October  2-4, 2017, London, UK; 3rd International Conference on Toxicogenomics  and Genomics, September 21-22, 2017, Toronto, Canada; 7th International Conference on Environmental Mutagens in Human Populations (ICEMHP), November 2016, Thailand; 11th International Particle Toxicology Conference September 26- 30 2016, Singapore; Argentine Toxicological Association 34th Interdisciplinary Toxicology Conference, September 21–23, 2016; Society of Toxicology’s 56th Annual Meeting, March 12–16, 2017, Baltimore, Maryland, USA; The XIV International Congress of Toxicology (ICTXIV), October 02-06, 2016, Mexico, ICT 2016; SETAC: Society of Environmental Toxicology and Chemistry; IUTOX: International Union of Toxicology; American College of Medical Toxicology; Argentine Toxicological Association; Austrian Society of Toxicology

Track 11: Pharmacological Testing  

Pharmacological Testing includes both Pharmacologic stress testing and nuclear stress test. Whereas the Pharmacologic stress testing is the set up after activity testing, is an analytic system in which cardiovascular anxiety affected by pharmacologic operators is shown in patients with diminished useful limit or in patients who can't work out. And Pharmacological nuclear stress test is a demonstrative test used to assess blood stream to the heart. Amid the test, a little measure of radioactive tracer is infused into a vein. A unique camera, called a gamma camera, identifies the radiation discharged by the tracer to create PC pictures of the heart.

Related Conferences: Pharmacological Testing Conferences | Pharmacovigilance Conferences | Pharmacology Conferences 

12th Euro-Global Summit on Applied Pharmacology and Toxicology, October  2-4, 2017, London, UK; 10th Global Conference on Applied Pharmacology  and Toxicology, July 24-26, 2017, Toronto, Canada; 15th International  Meeting on Clinical Pharmacology  and Toxicology, December 14-16, 2017, Dubai, UAE; 9th Global Toxicology and Pharmacology Meeting, July 17-19, 2017, Lisbon, Portugal; 11th International Symposium on Environmental Toxicology and Ecological Risk Assessment, September 21-22, 2017, Toronto, Canada; 3rd International Symposium on Toxicogenomics  and Genomics, September 21-22, 2017, Toronto, Canada; 13th International Summit on Cancer Biology  and Genetic Toxicology, November 2-3, 2017, San Antonio, USA; 14th International  Clinical Toxicology Meeting , November 2-3, 2017, San Antonio, USA; 16th International Congress on Occupational Toxicology and Industrial Health, December 14-15, 2017, Dubai, UAE; Australasian Society of Clinical and Experimental Pharmacologists & Toxicologists-MPGPCR 2016 Joint Scientific Meeting, November 27–30, 2016, Melbourne, Australia; The XIV International Congress of Toxicology (ICTXIV), October 02-06, 2016, Mexico, ICT 2016; Society of Toxicology 56th Annual Meeting, March 12–16, 2017, Baltimore, Maryland, USA; American College of Toxicology- 37th Annual Meeting on Toxicology, November 6–9, 2016, Baltimore Marriott Waterfront, Baltimore, Maryland; ANZFSS 23rd International Symposium on the Forensic Sciences, 18-23 September, 2016, New Zealand; ASIATOX; Australasian College of Toxicology & Risk Assessment (ACTRA); Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT); Austrian Society of Toxicology (ASTOX); Bangladesh Society of Toxicology (BDSOT); Slovenian Society of Toxicology

Track 12: Medicine Development and Safety Testing

Medicine Development includes many new medications or chemicals which may influence the strength of people are required by law to be tried on creatures. The safety tests provide data for arranging human trials; speak to a little extent of the advancement procedure for another medication. The tests can't anticipate the greater part of the responses a human may have to a given substance, more extensive inquiries concerning impacts on the heart, liver, lungs or skin are replied through creature concentrates so that its relative danger is known. Intense poisonous quality tests, where a solitary, high dosage of a substance is given to creatures, are performed right off the bat being developed.

Related Conferences: Toxicity Testing ConferencesHuman Toxicology Conferences | Medical Toxicology Conferences

3rd International Conference on Toxicogenomics  and Genomics, September 21-22, 2017, Toronto, Canada; 15th International  Summit on Toxicology and Clinical Pharmacology, December 14-16, 2017, Dubai, UAE; 12th Euro-Global Summit on Applied Pharmacology and Toxicology, October  2-4, 2017, London, UK;  14th International  Clinical Toxicology Meeting , November 2-3, 2017, San Antonio, USA; 11th International Conference on Environmental Toxicology and Ecological Risk Assessment, September 21-22, 2017, Toronto, Canada; 16th International Conference on Occupational Toxicology and Industrial Health, December 14-15, 2017, Dubai, UAE; 9th Global Pharmacology and  Toxicology Meeting, July 17-19, 2017, Lisbon, Portugal; 10th Global Summit on Applied Pharmacology  and Toxicology, July 24-26, 2017, Toronto, Canada; 13th International Conference on Cancer Biology  and Genetic Toxicology, November 2-3, 2017, San Antonio, USA; ANZFSS 23rd International Symposium on the Forensic Sciences, 18-23 September, 2016, New Zealand; 9th Annual Australasian College of Toxicology & Risk Assessment, September 22–23, 2016, Adelaide, Australia; 53rd European Congress of the European Societies of Toxicology, September 10–13, 2017, Bratislava, Slovakia; Australasian Society of Clinical and Experimental Pharmacologists & Toxicologists-MPGPCR 2016 Joint Scientific Meeting, November 27–30, 2016, Melbourne, Australia; 19th International Congress on In Vitro Toxicology– French Society of Toxicology, ESTIV & SPTC Joint Congress, October 17–20, 2016, Juan-les-Pins, France; Academy of Toxicological Sciences; IUTOX: International Union of Toxicology; German Society of Toxicology; EUROTOX; SOT: Society of Toxicology

About Conference

Organising successful conferences has been at the core of Conference Series LLC. We are delighted to organize the 8th World Congress on Toxicology and Pharmacology during April 13-15, 2017 at Dubai, UAE. This global event mainly focuses on “Communing Toxicology & Pharmacology Investigations for Human Health.”

Toxicology Congress 2017 offers a unique platform to present and know the latest updates with a complete approach to diverse areas of interest.  As the said by Paracelsus (1493-1541) ‘father of Toxicology’ goes “All things are with poison and nothing is without poison; only the dose can make a thing not poisonous”. Toxicology deals with the study of the correlation between the dose and its subsequent therapeutic effect. The therapeutic effect can convert to toxic effect with the increase in the level of dose. Toxicological studies starts right from the preclinical drug development. These studies are supported by advanced techniques such as In vivo imaging.

Conference Series LLC organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Why Toxicology Congress 2017??

At Toxicology Congress 2017 you can meet the world leading toxicologists, pharmacologists, clinical research professionals, biochemists and also the industrialists who will provide you with the latest innovations and scientific approaches thus help you in widening your scientific knowledge.

The topics of the Congress will reflect the recent advances, current trends, future trends and new approaches in Toxicology and Pharmacology.  The congress will cover among others:  Mechanisms and modes of action of various toxins, Clinical and Forensic toxicology, Emerging in vitro models, Medicine Development and Safety Testing, Regulatory toxicology and last but not least, a broad scope of pharmacology and toxicology in different fields.

Thus, our objective is, to create platforms which will gather eminent scientists who will undoubtedly enrich our congress during the Q&A sections.

Target Audience:

  • Academicians including Professors
  • PhD Scholars
  • Students carrying out laboratory and field studies
  • Pharmaceutical Industrial Giants
  • Toxicology Societies and the people Associated
  • Nobel laureates in Health Care and Medicine
  • Pharmacists
  • Pharmacologists
  • Toxicology Professionals
  • Genetic Professionals
  • Pathology Professionals
  • Forensic Professionals
  • Pharmaceutical companies
  • Clinical Laboratories and Technicians 
  • Bio-informatics Professionals
  • Research Institutes and members
  • Supply Chain companies
  • Manufacturing Companies
  • Training Institutes
  • Business Entrepreneurs

Market Analysis

Market Analysis

The global in vitro toxicology testing market is segmented on the basis of products, type, toxicity endpoints & tests, technology, method, and industry. On the basis of product, the market is segmented into assays, reagent & labware and services. Of these, the assays product segment accounted for the largest share of the global in vitro toxicology testing market in 2016, large share of this segment can primarily be attributed to the to the increasing use of assays for testing various toxicity endpoints and the higher frequency of purchase of these assays as compared to reagents & labware. On the basis of industry, the market is segmented into cosmetics & household products, pharmaceutical, diagnostics, chemical, & food. Of these, the cosmetics & household products industry segment accounted for the largest share of the global in vitro toxicology testing market in 2016, large share of this segment is due to the compulsory ban of animal testing across the cosmetics industry with a ban on marketing finished products and cosmetic ingredients.

The geographic segments included in this report are Europe, North America, Asia, and Rest of the World. Geographic analysis reveals that Europe accounted for the largest share of the global in vitro toxicology testing market in 2016. Growth in this market can be attributed to the opposition of animal testing, and increasing R&D to detect toxicity at early stages.

Why UAE?

UAE is the second largest pharmaceutical market in the gulf region. It is the regional leader in the manufacturing of pharmaceutical products and it is likely to grow steadily for some years. The total market value is estimated at US$ 1.8 Billion. Strong government support has resulted in growth of healthcare segment. Previously many of the drugs used to be imported but now due to government support local manufacturing of drugs is promoted. Use of generic drugs is promoted to reduce the healthcare cost. Many multinational companies started their operation in Dubai in order to access the market and develop drugs.

Many of the multinational top pharmaceutical companies have established their regional centers in Dubai so as to cover the entire regional market. Adoption of western culture, increase in population and economic activities and integration with international market has led to many companies coming to this region. Gulf Pharmaceutical industries (Julphar) are the largest and oldest pharmaceutical companies in the market. It distributes its products in the market and is focusing on local production. It has developed alliances with many companies for drug production.

Congress Highlights:

  • Toxicology
  • Toxicology and Risk Assessment
  • Analytical Toxicology
  • Genotoxicity
  • Forensic Toxicology
  • Food Safety and Environmental Toxicology
  • Toxicology Applications
  • Pharmacology
  • Applied Pharmacology
  • Environmental Pharmacology
  • Pharmacological Testing
  • Medicine Development and Safety Testing
  • Experimental and Toxicologic Pathology
  • Medical and Clinical Toxicology
  • Toxicology Testing

Major Associations around the Globe:

  • Society of Toxicology, USA (SOT)
  • Society of Toxicology of Canada
  • Latin American Association of Toxicology (ALATOX)
  • Japanese Society of Toxicology
  • Italian Society of Toxicology
  • German Society of Toxicology
  • EUROTOX
  • British Toxicology Society
  • French Society of Toxicology
  • International Society of Regulatory Toxicology and Pharmacology

List of top Pharmaceutical companies in UAE-Dubai:

  • Pfizer UAE
  • Merck UAE
  • Gulf Pharmaceutical Industry-Julphar (JULPHAR)
  • Hikma Pharmaceuticals PLC
  • Al-Hayat Pharmaceut  icals
  • Elis Pharmaceuticals Limited
  • Sanofi Aventis UAE
  • Ranbaxy Laboratories Limited
  • GlaxoSmithKline
  • Saga Pharmaceuticals
  • Astra Zeneca UAE
  • Baxter A.G
  • Johnson & Johnson Middle East
  • Novo Nordisk Pharma Gulf
  • Smart Health and Nutrition Ltd.
  • Valeant Pharmaceuticals MEA FZ LLC
  • Amgen
  • Alliance Global
  • Genpharm
  • BioPharma
  • Gulf Inject
  • Global Pharma
  • Neopharma
  • Medpharma

Top Universities in the UAE:

  • United Arab Emirates University             
  • Higher Colleges of Technology   
  • American University of Sharjah
  • University of Sharjah     
  • Zayed University             
  • Masdar Institute of Science and Technology        
  • American University in Dubai   
  • University of Wollongong in Dubai          
  • Ajman University of Science and Technology      
  • Khalifa University

Funding Agencies in UAE:

  • National Research Foundation
  • Khalifa Fund
  • Emirates Foundation
  • Sheikh Saud Bin Saqr Al Qasimi Foundation for Policy Research
  • Mohammed bin Rashid Al Maktoum Foundation
  • Mohammed bin Rashid Est. for Young Business Leaders (part of Zayed University)
  • Community Development Authority
  • Dubai International Award for Best Practices
  • Arab Fund for Economic & Social Development
  • Qatar National Research Fund
  • National Science Foundation
  • Arab Science and Technology Foundation
  • Global Development Network: MENA Region (based in India)
  • Gulf Research Center (GRC)
  • Higher Education Funding Opportunities in the Arab Region

Target Audience:

  • Professors
  • PhD Scholars
  • Students carrying out laboratory and field studies
  • Pharmaceutical Industrial Giants
  • Toxicology Societies and the people Associated
  • Noble laureates in Health Care and Medicine
  • Pharmacists
  • Genetic Professionals
  • Forensic Professionals
  • Toxicology Professionals
  • Pathology Professionals
  • Clinical Laboratories and Technicians 
  • Bio instruments Professionals
  • Bio-informatics Professionals
  • Software development companies
  • Research Institutes and members
  • Supply Chain companies
  • Manufacturing Companies
  • Training Institutes
  • Business Entrepreneurs

Figure: Statistical Analysis

Glance at the Market:

The global in vitro toxicology testing market is expected to USD 27.36 Billion by 2021 from USD 14.15 Billion in 2016, at a CAGR of 14.1% between 2016 and 2021. Toxicity testing of new compounds is  essential in drug development, as identifying the potential toxicity at an early stage in drug discovery can save both time and developmental costs, and also reduce the likelihood of late-stage failure.

Opposition to animal testing, new & promising technologies, increasing R&D to detect toxicity at early stages and insufficient databases to facilitate the use of in vitro test methods are driving factors of the in vitro toxicology testing market. On the other hand lack of in vitro models to detect autoimmunity and immunostimulation and predictive ability of in vitro testing over in vivo testing are the major factor restraining the growth of this market.

Figure: Global In Vitro Toxicity Market Estimates and Forecast, 2011-2021 (USD Billions)

Glance at the Pharmaceutical Market in UAE:

In 2013, the UAE's population stood at 9 million, an increase from 8.1 million in 2008. The United Arab Emirates' pharmaceutical market was estimated to have been worth $2.4 billion in 2013 and is expected to reach $3.7 billion by 2020 at a projected Compound Annual Growth Rate (CAGR) of 5.3%. The UAE's medical device market was valued at approximately $600.2m in 2008, and $733.3m in 2013. The medical device market is estimated to reach $978.9m in 2020 at a CAGR of 4.2% from 2014. The positive trends in UAE's healthcare market can primarily be attributed to the increasing coverage of healthcare insurance and government initiatives to improve healthcare facilities.

Figure: UAE's Pharmaceutical Market Estimates and Forecast, 2011-2020 (USD Billions)

Pharmaceuticals & Healthcare in UAE:

Headline Pharmaceuticals & Healthcare Forecasts (United Arab Emirates 2014-2020)

 

2014

2015

2016f

2017f

2018f

2019f

2020f

f = BMI forecast. Source: WHO, National Sources, BMI

Pharmaceutical sales, USDbn

4.450

2.930

3.170

3.410

3.670

3.940

4.220

Pharmaceutical sales, % of GDP

1.11

0.79

0.81

0.83

0.85

0.86

0.87

Pharmaceutical sales, % of health expenditure

30.4

19.2

19.7

20.2

20.6

20.9

21.2

Health spending, USDbn

14.630

15.320

16.080

16.910

17.820

18.820

19.930

 

Figure: Pharmaceutical sales in UAE (USD Billions)

 

The UAE is one of the most rewarding markets for pharmaceutical and healthcare providers in the Middle East and African region. It has a fast-growing private healthcare sector, which brings with it demand for innovative and patented drugs.

Past Conference Report

Toxicology 2016

6th Global Summit on Toxicology and Applied Pharmacology was hosted by the Conference Series LLC in Houston, USA during October 17-19, 2016. The conference was focused on the theme "Bringing together leading researchers to share pragmatic insights" and facilitated by the Conference Series LLC. Liberal reaction and cooperation was received from the Editorial Board Members of Conference Series LLC Journals, Toxicology-2016Organizing Committee Members, and from researchers, analysts and pioneers in Toxicology.

The conference was started by the Keynote Forum and we are chuffed to thank all our Keynote Speakers, Honorable Guests, Speakers and Conference Attendees for creating a successful meeting.

The conference has encrusted through the following sessions:

  • Toxicology
  • Food and Chemical Toxicology
  • Drug Toxicology
  • Pharmacology and Toxicology
  • Toxicology Studies
  • Environmental Toxicology
  • Human Toxicology
  • Applied Pharmacology
  • Toxicology Risk Assessment
  • Toxicity Testing
  • Genetic Toxicology
  • Toxicology Current Advances

We would like to specially mention our Keynote Speakers who participated very enthusiastically and actively

  • Alexei G Basnakian, University of Arkansas for Medical Sciences, USA
  • István Fábián, University of Debrecen, Hungary
  • Lawrence C Sowers, University of Texas, USA
  • G Jean Harry, National Institute of Environmental Health Science, USA

The speakers gave their productive commitment as exceptionally enlightening presentations and made the meeting an extraordinary achievement.

We thank all the members who supported the conference by encouraging the healthy discussions. Conference Series LLC expresses gratitude to the Organizing Committee Members for their generous nearness, support and help towards Toxicology-2016


Past Reports  Proceedings  Gallery  

Toxicology 2015

Toxicology 2015 Past Conference Report

OMICS International is the proud host of the 4th Global Summit on Toxicology which took place in Philadelphia, USA during August 24-26, 2015 with the theme, “Exploring the Tailored Strategies and Lucid Technologies in Toxicology and Pharmacology”. The Editorial Board Members of OMICS Group Journals and the Organizing Committee Members of the conference have extended their unsparing support and active participation towards Toxicology 2015. The participants included eminent speakers, scientists, industrialists, delegates, researchers and students who thoroughly relished the conference.   

The core of the conference revolved around interactive sessions on the following scientific tracks:

  • Organ System Toxicity
  • Applied Toxicology
  • Genetic Toxicology
  • Toxicity Testing Market & Business Opportunities
  • Environmental Toxicology
  • Regulatory Toxicology
  • Applied Pharmacology
  • Biotoxins
  • Pharmacovigilance & Toxicologists Meeting

This event is a collaborative effort and OMICS would like to thank the following people for making this conference a grand success:      

Moderators

  • Mary M Staehle, Rowan University, USA
  • Kim Elizabeth Strifert, University of Alabama at Birmingham, USA

Keynote Speakers

  • Diana Anderson, University of Bradford, UK
  • P Sampath Kumar, Sri Ramachandra Medical College & Research Institute, India

We would sincerely thank the distinguished speakers who resplendently conducted workshops on Genotoxicity:

  • Leon F Stankowski from Genetic Toxicology Association, USA on the topic “Genotoxicity: Basic aspects and most commonly worldwide employed and validated in vitro assays”.
  • Rohan Kulkarni from BioReliance, USA on “Genotoxicity: Basic aspects and most commonly worldwide employed and validated in vivo assays”.
  • Marcelo L Larramendy from National University of La Plata, Argentina on the topic “Genotoxicity in non-traditional animal models”.
  • Kamala Pant from BioReliance, USA on the topic “Genetic toxicity screening assays”.
  • Daniel J Roberts from Bristol-Myers Squibb, USA on “Genotoxicity and industry: Utilizing genetic toxicity assays to support pharmaceutical development”.                                                

The conference marked its start by an opening ceremony which included introduction by the Honorable Guests and the Members of Keynote Forum. All the speakers have extended their contribution in the form of highly informative presentations to lead the conference to the ladder of success. OMICS extends its warm gratitude towards all the Participants, Eminent Speakers, Young Researchers, Delegates and Students.

All accepted abstracts have been indexed in OMICS Group journal, the Journal of Clinical Toxicology as a special issue.

After the huge optimistic response from scientific fraternity, renowned personalities and the Editorial Board Members of OMICS Group from across the world, OMICS is pleased to announce the 5th Global Summit on Toxicology and Applied Pharmacology to be held during October 17-19, 2016 in Houston, USA.

We look forward to welcoming you to the Toxicology 2016 Conference and hope that the event will be both informative and enjoyable.


Past Reports  Proceedings  Gallery  

Toxicology-2014
Toxicology 2014 Past Conference Report

The 3rd International Summit on Toxicology & Applied Pharmacology took place inChicago, USA on October 20-22, 2014. The conference was titled: “New Challenges and Innovations in Pharmacological and Toxicological Sciences” and hosted by the OMICS Group. Generous response and active participation was received from the Editorial Board Members of OMICS Group Journals, Toxicology-2014 Organizing Committee Members, as well as from scientists, researchers and leaders in Toxicology.

Students from various parts of the world took active participation in poster presentations. Students who presented well were awarded Best Poster Presentations for their outstanding contribution in the field of Toxicology.

The conference was carried out through various sessions and the discussions were held on the following scientific tracks:

  • Clinical and Forensic Toxicology
  • Mechanistic and Predictive Toxicology
  • Toxicology and Applied Pharmacology
  • Environmental and Occupational Health
  • Application of Stem Cells in Toxicology
  • Risk Assessment of Chemicals in Food
  • Emerging In-vitro Models for the Toxicity Studies
  • Industrial and Metallic Toxicology
  • Developmental and Reproductive Toxicology
  • Computational Toxicology
  • Nanomaterials
  • Venomous Animals and Toxins
  • Countersteps towards Toxicity

The conference was opened by introductions from the honorable guests and members of the keynote forum. On the first day of opening the keynote speakers were,

Gerhard Eisenbrand, University of Kaiserslautern, Germany

Pavel Vodicka, Institute of Experimental Medicine, Czech Republic

Anne Marie Vinggaard, Technical University of Denmark, Denmark

Special session was conducted by Carter Cliff, Cellular Dynamics International, USA on the topic “Pluripotent stem cell models-Application in toxicology and beyond”, Heres-Pulido M E, Universidad Nacional Autónoma de México, Mexico on the topic “The Somatic Mutation and Recombination Test (SMART) in Drosophila melanogaster”.

Symposium conducted by Cinzia Forni from University of Rome Tor Vergata, Italy and Hemant Misra from Prolong Pharmaceuticals, USA and the title of the Symposium is “Stress response in living organisms exposed to pollutants”.

All the speakers gave their fruitful contribution in the form of highly informative presentations and made the conference a great success.

All accepted abstracts have been indexed in OMICS Group Journal of Clinical Toxicologyas a special issue.


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date April 13-15, 2017

For Sponsors & Exhibitors

Sponsorship Opportunities

Speaker Opportunity

Supported By

Toxicology: Open Access Journal of Clinical Toxicology Journal of Forensic Toxicology & Pharmacology Journal of Drug Metabolism & Toxicology

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators

Media Partner

Media Partner

Media Partner

Media Partner

Media Partner

Media Partner

Media Partner

Media Partner

Media Partner

Media Partner

Media Partner

Media Partner

Media Partner

Media Partner